Studies systematically comparing the performance of health-related quality-of-life (HRQoL)
instruments in pulmonary arterial hypertension (PAH) are lacking. We sought to address this …

Emotional and psychological difficulties cannot fully be explained by disease‐related factors
in people with pulmonary hypertension (PH). This study examined the relationship between …

Background Patient-centered health care for patients with pulmonary hypertension (PH) is
important and requires an understanding of patient experiences. However, there is a lack of …

Purpose: To describe symptoms experienced by pulmonary arterial hypertension (PAH)
patients and the impact these symptoms have had on their lives. Method: Qualitative …

About half of all patients with pulmonary hypertension (PH) experience psychological and
emotional disturbances that affect their quality of life (QOL). There is a lack of studies …

A poor quality of life (QoL) in patients with pulmonary hypertension (PH) is often associated
with emotional disturbances and the ability to cope. Little is known, however, about the …

Rationale: Pulmonary arterial hypertension is a progressive disease with high morbidity and
mortality despite advances in medical therapy. The relationship between patient-related …

Objectives Pulmonary arterial hypertension (PAH) is a rare disorder with unfavorable
prognosis despite implementation of specific PAH-oriented therapy. The aim of the study …

In recent years new therapeutic options have been developed for the management of
pulmonary arterial hypertension (PAH). Sitaxsentan is an oral, once daily, highly selective …

Objective Pulmonary arterial hypertension (PAH) is a rare disease. Although muscle
strength, exercise capacity, quality of life, and activities of daily living of patients with PAH …